Licence For Publication of an International Agency for Research on Cancer (IARC)
Manuscript as an Article in a journal
1. John Wiley & Sons, the Wiley publishing entity identified in the journal (“the Publisher”), is responsible for the publication of a journal for itself or on
behalf of the society or other organization identified in the Journal entitled(“the Journal”).

The International Agency for Research on Cancer, a specialized agency of the World Health Organization (“IARC/WHO”) will submit a manuscriptto the Publisher entitled(the“Manuscript”), which the Publisher will prepare to become an article (the “Article”) to be published in the Journal upon acceptance.
2. I A R C / WHO hereby grants the Publisher a non-exclusive, worldwide, royalty-free licence for the term of copyright and any extensions thereof, topublish, re-publish, transmit, sell, distribute and otherwise use the Manuscript as an Article in the Journal, in whole or as a part. This licence covers bothelectronic and print editions of the Journal as well as derivative works in all languages and in all media of expression now known or later developed, and tolicense or permit others to do so. The Article shall not be used to support the promotion of any third party commercial products or services.
3. Copyright in the Manuscript remains exclusively vested in IARC/WHO and no rights, other than the ones explicitly provided herein, are being granted.
Notwithstanding the non-exclusive rights granted above, IARC/WHO agrees not to submit the Manuscript as a whole for publication by anothercommercial or scholarly journal publisher, although part(s) of the Manuscript may be published with other commercial or scholarly publishers, either on
their own or as part(s) of other works. For the avoidance of any doubt, IARC/WHO retains the right to deal with the Manuscript as well as all its derivative works
in all languages in any way, manner and format it may wish, as a whole or in part, including (i) the posting of the accepted author manuscript (after peer
review, but before copyediting and typesetting) in Europe PubMed Central and in the IARC/WHO public institutional repository subject to an embargo periodof 12 months after publication of the Article, and (ii) publishing it in electronic or print editions, whether itself or through third parties, provided that it is not
published in another commercially available or scholarly journal.
4. The copyright in the Article in its peer-reviewed and published versions, as well as in the Journal, is vested in the Publisher or the Publisher’s licensor. The
Publisher shall provide IARC/WHO with one complimentary copy of the Article and grants IARC/WHO the licence to;(i) cite, use and publish in any manner and format tables, figures and extracts from the Article;(ii) copy and distribute the Article internally in print format or electronically on IARC/WHO’s internal network, provided such copies are notresold, ordistributed externally except as part of an information pack distributed by IARC/WHO;(iii) re-use the Article or parts thereof in any publication authored or edited by IARC/WHO or by an author of the Manuscript (excluding journal articles)
where such re-used material constitutes less than half of the total material in such publication. In such case, any modifications should be accuratelynoted.
(iv) the right to send or transmit individual copies of the Article in any format upon specific request, to share copies in private sharing groups ina Scholarly Collaboration Network (SCN) which has signed up to the STM article sharing principles [http://www.stm-assoc.org/stm-consultations/scn-consultation-2015/], provided no fee is charged, and further provided that there is no systematic external or public distributionof the Contribution, e.g. posting on a listserve, network or automated delivery.
5. The Publisher shall acknowledge in the Journal, in an acknowledgement consistent with the style of acknowledgements in the Journal, IARC/
WHO’s copyright in the Manuscript and permission to publish the Manuscript as an Article in the Journal.
6. I A R C / WHO confirms that it is legally entitled to grant the Publisher the aforesaid rights. To the best of IARC/WHO’s knowledge, the Manuscript does notviolate or infringe on the rights of any third party. I A R C / WHO has exercised reasonable care to ensure that the Manuscript is accurate. The Publisher agrees toensure that the content of the Article is an accurate reflection of the content of the Manuscript.
7. Any dispute relating to the interpretation or application of this Agreement shall, unless amicably settled, be subject to conciliation. In the event offailure of the latter, the dispute shall be settled by arbitration. The arbitration shall be conducted in accordance with the modalities to be agreed upon by theparties or, in the absence of agreement, with the rules of arbitration of the International Chamber of Commerce. The parties shall accept the arbitral award
as final. Nothing in or relating to this Agreement shall imply the obligation of IARC/WHO to submit to any national legislation or jurisdiction, or be deemeda waiver of any of the privileges and immunities of IARC/WHO in conformity with the Convention on the Privileges and Immunities of the Specialized
Agencies approved by the General Assembly of the United Nations on November 21, 1947 or otherwise under any national or international law, convention
or agreement.

Agreed and accepted on behalf of IARC/WHO

Signature
Name
Title
Date

Agreed and accepted on behalf of the Publiser

Signature
Name
Title
Date